Stockreport

A Look At Viking Therapeutics (VKTX) Valuation As VK2735 Phase 3 Enrollment Reaches Completion [Yahoo! Finance]

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
PDF Viking Therapeutics (VKTX) shares are back in focus after the company completed enrollment in VANQUISH-2, its Phase 3 trial of obesity and type 2 diabetes drug candidat [Read more]